Reduced Dose Bolus Alteplase vs Conventional Alteplase Infusion for Pulmonary Embolism Thrombolysis

This publication has 16 references indexed in Scilit:

• Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion
  The Lancet, 1993
• Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism
  The American Journal of Cardiology, 1992
• Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial
  Journal of the American College of Cardiology, 1992
• Intracranial hemorrhage after rt-pa and heparin for acute myocardial infarction — The TIMI II pilot and randomized trial combined experience
  Journal of the American College of Cardiology, 1990
• RANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISM
  The Lancet, 1988
• Perspectives on Treatment of Acute Pulmonary Embolism with Tissue Plasminogen Activator
  Seminars in Thrombosis and Hemostasis, 1987
• Design and analysis of group sequential tests based on the type I error spending rate function
  Biometrika, 1987
• ACUTE PULMONARY EMBOLISM TREATED WITH TISSUE PLASMINOGEN ACTIVATOR
  The Lancet, 1986
• Group sequential methods for clinical trials with a one-sided hypothesis
  Biometrika, 1980
• Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
  Acta Haematologica, 1957